iSirona becomes a part of NANTHEALTH

Effective January 1, 2014, iSirona will become a part of NantHealth. NantHealth is a healthcare IT company that combines science, technology and data to provide actionable information that enables better diagnostics, improved patient care and advanced wellness for all. This partnership will expand iSirona’s ability to bring exciting, forward-thinking solutions to iSirona clients—and to the healthcare marketplace at large. via Medical Device Connectivity and Medical Device Integration Solutions |...

BlackLine Systems Wins Prestigious Patrick Soon-Shiong Innovation Award

BlackLine Systems Wins Prestigious Patrick Soon-Shiong Innovation Award Annual honors presented by the Los Angeles Business Journal recognize financial close software company’s advancements in product innovation, client service By BlackLine Systems ,  Nov. 18, 2013 LOS ANGELES, Nov. 18, 2013 — /PRNewswire/ — Enterprise-class financial software company BlackLine Systems was honored last week with a Patrick Soon-Shiong Innovation Award, recognizing the company for innovation stemming from the simple concept of leveraging technology to optimize and automate accounting processes to help companies save time, reduce costs and make life easier for those working in corporate accounting and finance departments. The Innovation Awards, presented annually by the Los Angeles Business Journal (LABJ), emphasize the importance of supporting innovation in order to foster the economic competitiveness of the Greater Los Angeles region. A past recipient of the LABJ‘s “Business Person of the Year” award and Innovation Awards sponsor/donor, Dr. Patrick Soon-Shiong knows as well as anyone that innovation, coupled with passion and hard work, is the engine for success in business.  Dr. Soon-Shiong’s groundbreaking concepts for curing diabetes led to the first nanotechnology-based breast cancer drug, Abraxane, which is credited with saving thousands of lives. Now, for the fourth year, his love of innovation has prompted him to once again join theLABJ in handing out the prestigious Patrick Soon-Shiong Innovation Awards. For years much of the work within accounting departments has been rote and manual-labor intensive. As a result, there’s been a tidal wave of outsourcing designed to cut costs. But by outsourcing accounting jobs, companies often lose the valuable analytical skills and strategic value that accountants should be adding. By developing software (for the first time) to automate critical accounting processes, BlackLine Systems CEO and Founder Therese...

GumGum Awarded Prestigious Patrick Soon-Shiong Innovation Award

GumGum Awarded Prestigious Patrick Soon-Shiong Innovation Award by the Los Angeles Business Journal LOS ANGELES, CA–(Marketwired – Nov 15, 2013) GumGum, the leading provider of in-image advertising, today announced that it is the recipient of the Los Angeles Business Journal’s 2013 Patrick Soon-Shiong Innovation Award. The prestigious honor celebrates organizations that stretch boundaries and advance the innovative and economic competitiveness of the Los Angeles region. The awards were handed out at a ceremony on November 14 at the Four Seasons Hotel Los Angeles in Beverly Hills. “Los Angeles is home to many of the most exciting and groundbreaking companies in the world — each striving to become a ‘game-changer’ through ingenuity and innovation,” said Matt Toledo, Publisher and CEO of the Los Angeles Business Journal. “It is with love and respect for great ideas that we are proud to present this year’s awards.” GumGum is among five companies to receive the honor. Other recipients included Blackline Systems, Campus Explorer, OEwaves, and SAFCell. “We are thrilled and humbled to be among the exceptional companies recognized for an award whose namesake is the living personification of changing the world by thinking outside of the box,” said GumGum founder and CEO Ophir Tanz. “It is a testament to our team’s hard work that we’re able to achieve such significant recognition as we continue to raise the bar for ingenuity in Silicon Beach.” About GumGum GumGum is the leading in-image advertising provider, driving brand engagement for advertisers and increased revenue for publishers across every screen. Founded in 2007, GumGum is credited with inventing in-image advertising and has since expanded its products to include...

Biological Chemotherapy Nanoparticle Developer Donates $4 M to UC Global Health Institute

UCLA faculty member’s foundation gives $4 million to UC Global Health Institute UCLA Newsroom | By Elaine Schmidt | November 04, 2013 The Los Angeles–based foundation was founded by Dr. Patrick Soon-Shiong, a UCLA faculty member, inventor and philanthropist, and his wife, Michele Chan, a television and film actress. “Students are demanding a global education, and one mission of the Global Health Institute is to prepare the next generation of global health leaders,” said institute co-director Thomas J. Coates, the Michael and Sue Steinberg Endowed Professor of Global AIDS Research and founding director of the Center for World Health at the David Geffen School of Medicine at UCLA and the UCLA Health System. “We provide students with real-world experiences and skills essential for their success in working with partners around the world to provide meaningful solutions to global health problems.” A part-owner of the Los Angeles Lakers who is ranked by Forbes as the wealthiest American in the health care industry and the wealthiest resident of Los Angeles, Soon-Shiong is an innovative entrepreneur who has pioneered groundbreaking treatments in diabetes and cancer. He is also executive director of the UCLA Wireless Health Institute and a UCLA visiting professor of bioengineering and of microbiology, immunology and molecular genetics. Soon-Shiong developed the nation’s first biological chemotherapy nanoparticle, called Abraxane, now approved for the treatment of breast cancer and lung cancer. Abraxane has succeeded in Phase 3 trials in pancreatic cancer and melanoma. He also created and later sold two multibillion-dollar companies, American Pharmaceutical Partners and Abraxis Bioscience. “We look at this gift not merely as a donation for today, but as...